| Announce Date | 08/28/2025 |
| EPS Normalized Actual | $0.2 (Beat by $0.07) |
| EPS GAAP Actual | $0.2 (Beat by $0.07) |
| Revenue Actual | $0.08179B |
| Revenue Surprise | Beat by $81.79M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $0.48 |
| EPS GAAP Estimate | $0.48 |
| Revenue Estimate | $0.098B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 0.575 | 16.82 | 0.56395 | 0.58565 | 1 |
| Dec 2026 | 2.0075 | 4.82 | 2.0075 | 2.0075 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 0.23 | -0.09408 | 0.08179B | -2.61% | -104.92M |
| FQ1 2025 (Mar 2025) | 0.17 | -0.29 | 0.081882B | 0.7% | -10.78M |
| FQ4 2024 (Dec 2024) | 0.51 | 0.51 | 0.081486B | -26.82% | 81.49M |
| FQ3 2024 (Sep 2024) | 0.15 | 0.15 | 0.078512B | 100% | 78.51M |
| FQ2 2024 (Jun 2024) | 0.49 | 0.49 | 0.083925B | 100% | 83.93M |
| FQ1 2021 (Mar 2021) | 2.51 | 2.51 | 0.043739B | 100% | 43.74M |
| FQ2 2021 (Jun 2021) | 2.51 | 2.51 | 0.043739B | 100% | 43.74M |
| FQ3 2021 (Sep 2021) | 0.81 | 0.81 | 0.037795B | 100% | 37.8M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
0.48
Consensus Revenue Estimates
0.098B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1 | -- | 0.92602 | 1.05139 | 1 |
| FQ3 2027 (Sep 2027) | 0.2 | -- | 0.2 | 0.2 | 1 |
| FQ2 2027 (Jun 2027) | 0 | -- | 0 | 0 | 0 |
| FQ1 2027 (Mar 2027) | 0.2 | -- | 0.1852 | 0.21028 | 1 |
| FQ4 2026 (Dec 2026) | 0.45647 | -- | 0.4227 | 0.47993 | 1 |
| FQ3 2026 (Sep 2026) | -0.10101 | -- | -0.10211 | -0.09987555 | 1 |
| FQ2 2026 (Jun 2026) | -0.20016 | 214.91 | -0.20233 | -0.19791 | 1 |
| FQ1 2026 (Mar 2026) | 0.2 | 15 | 0.19306 | 0.20571 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.12B | -- | 0.11B | 0.12B | 2 |
| FQ3 2027 (Sep 2027) | 0.08B | -- | 0.08B | 0.08B | 2 |
| FQ2 2027 (Jun 2027) | 0.07B | -- | 0.07B | 0.07B | 2 |
| FQ1 2027 (Mar 2027) | 0.08B | -- | 0.07B | 0.08B | 2 |
| FQ4 2026 (Dec 2026) | 0.09B | -- | 0.09B | 0.1B | 2 |
| FQ3 2026 (Sep 2026) | 0.13B | -- | 0.13B | 0.13B | 1 |
| FQ2 2026 (Jun 2026) | 0.12B | 32.1 | 0.12B | 0.12B | 1 |
| FQ1 2026 (Mar 2026) | 0.08B | -4.98 | 0.08B | 0.08B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 0.32408 | 0.23 | -0.09408 | -40.9% |
| FQ1 2025 (Mar 2025) | 0.46 | 0.17 | -0.29 | -170.59% |
| FQ4 2024 (Dec 2024) | 0.51 | 0.51 | 100% | |
| FQ3 2024 (Sep 2024) | 0.15 | 0.15 | 100% | |
| FQ2 2024 (Jun 2024) | 0.49 | 0.49 | 100% | |
| FQ1 2021 (Mar 2021) | 2.51 | 2.51 | 100% | |
| FQ2 2021 (Jun 2021) | 2.51 | 2.51 | 100% | |
| FQ3 2021 (Sep 2021) | 0.81 | 0.81 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $0.19B | $0.08B | $-104.92M | -128.28% |
| FQ1 2025 (Mar 2025) | $0.09B | $0.08B | $-10.78M | -13.17% |
| FQ4 2024 (Dec 2024) | $0B | $0.08B | $81.49M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.08B | $78.51M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.08B | $83.93M | 100% |
| FQ1 2021 (Mar 2021) | $0B | $0.04B | $43.74M | 100% |
| FQ2 2021 (Jun 2021) | $0B | $0.04B | $43.74M | 100% |
| FQ3 2021 (Sep 2021) | $0B | $0.04B | $37.8M | 100% |